tradingkey.logo
๎™
๎™ผ
tradingkey.logo
๎™

Baird Medical Investment Holdings Ltd

BDMD
1.860USD
-0.170-8.37%
์ข…๊ฐ€ย 03/30, 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
46.50M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM
๎™

Baird Medical Investment Holdings Ltd

1.860
-0.170-8.37%

์ž์„ธํ•œ ๋‚ด์šฉ์€ Baird Medical Investment Holdings Ltd ํšŒ์‚ฌ

Baird Medical Investment Holdings Ltd is a company mainly engaged in the microwave ablation medical device business. The Company is mainly engaged in the provision of microwave ablation medical device. The medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps.

Baird Medical Investment Holdings Ltd ์ •๋ณด

๎™Œ
์ข…๋ชฉ ์ฝ”๋“œ BDMD
ํšŒ์‚ฌ ์ด๋ฆ„Baird Medical Investment Holdings Ltd
์ƒ์žฅ์ผDec 13, 2021
CEOWu (Haimei)
์ง์› ์ˆ˜143
์œ ํ˜•Ordinary Share
ํšŒ๊ณ„ ์—ฐ๋„ ์ข…๋ฃŒDec 13
์ฃผ์†Œ18/F, Ovest
๋„์‹œGUANGZHOU
์ฆ๊ถŒ ๊ฑฐ๋ž˜์†ŒNASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐ€China
์šฐํŽธ ๋ฒˆํ˜ธ- -
์ „ํ™”
์›น์‚ฌ์ดํŠธhttps://ir.bairdmed.com/
์ข…๋ชฉ ์ฝ”๋“œ BDMD
์ƒ์žฅ์ผDec 13, 2021
CEOWu (Haimei)

Baird Medical Investment Holdings Ltd์˜ ํšŒ์‚ฌ ์ž„์›์ง„

๎™Œ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Ms. Haimei Wu
Ms. Haimei Wu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
18.30M
--
Mr. Joe Ragan
Mr. Joe Ragan
Director
Director
--
--
Mr. Wei Hou
Mr. Wei Hou
Director
Director
--
--
Ms. Quan Qiu
Ms. Quan Qiu
Chief Administrative Officer, Director
Chief Administrative Officer, Director
--
--
Prof. Mingzhao (Michael) Xing
Prof. Mingzhao (Michael) Xing
Independent Director
Independent Director
--
--
Mr. Lijian Xu
Mr. Lijian Xu
Independent Director
Independent Director
--
--
Ms. Gabrielle Bilciu-Wolfson
Ms. Gabrielle Bilciu-Wolfson
Independent Director
Independent Director
--
--
Mr. Rongjian Lu
Mr. Rongjian Lu
Chief Technology Officer, Deputy General Manager
Chief Technology Officer, Deputy General Manager
--
--
Ms. Jie Li
Ms. Jie Li
Acting Chief Financial Officer
Acting Chief Financial Officer
--
--
Mr. Jianwei Yuan
Mr. Jianwei Yuan
Production Department Manager
Production Department Manager
--
--
๋” ๋ณด๊ธฐ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Ms. Haimei Wu
Ms. Haimei Wu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
18.30M
--
Mr. Joe Ragan
Mr. Joe Ragan
Director
Director
--
--
Mr. Wei Hou
Mr. Wei Hou
Director
Director
--
--
Ms. Quan Qiu
Ms. Quan Qiu
Chief Administrative Officer, Director
Chief Administrative Officer, Director
--
--
Prof. Mingzhao (Michael) Xing
Prof. Mingzhao (Michael) Xing
Independent Director
Independent Director
--
--
Mr. Lijian Xu
Mr. Lijian Xu
Independent Director
Independent Director
--
--

์ˆ˜์ต ๋ถ„์„

ํ†ตํ™”: USD๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Tue, Jan 6
ํ†ตํ™”: USD๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Tue, Jan 6
FY2024
FY2023
์‚ฌ์—…๋ณ„USD
์ด๋ฆ„
์ˆ˜์ต
๋น„์œจ
MWA Needles
33.83M
91.33%
MWA Therapeutic Apparatus
3.20M
8.64%
Other Medical Devices
9.83K
0.03%
์ง€์—ญ๋ณ„USD
์ด๋ฆ„
์ˆ˜์ต
๋น„์œจ
China (Mainland)
37.04M
100.00%
์‚ฌ์—…๋ณ„
์ง€์—ญ๋ณ„
์‚ฌ์—…๋ณ„USD
์ด๋ฆ„
์ˆ˜์ต
๋น„์œจ
MWA Needles
33.83M
91.33%
MWA Therapeutic Apparatus
3.20M
8.64%
Other Medical Devices
9.83K
0.03%

์ฃผ์‹ ๋ณด์œ  ํ†ต๊ณ„

๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Wed, Feb 25
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Wed, Feb 25
์ฃผ์ฃผ
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
Wu (Haimei)
49.82%
ExcelFin SPAC LLC
13.00%
Grand Fortune Capital (H.K.) Co, Ltd.
6.71%
Periscope Capital
0.34%
Highbridge Capital Management, LLC
0.34%
๊ธฐํƒ€
29.79%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
Wu (Haimei)
49.82%
ExcelFin SPAC LLC
13.00%
Grand Fortune Capital (H.K.) Co, Ltd.
6.71%
Periscope Capital
0.34%
Highbridge Capital Management, LLC
0.34%
๊ธฐํƒ€
29.79%
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
๋น„์œจ
Individual Investor
49.82%
Corporation
19.71%
Hedge Fund
0.91%
Investment Advisor/Hedge Fund
0.41%
Investment Advisor
0.09%
Bank and Trust
0.03%
๊ธฐํƒ€
29.03%

๊ธฐ๊ด€ ์ฃผ์‹ ๋ณด์œ 

๎™Œ
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Mon, Dec 8
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Mon, Dec 8
๋ณด๊ณ  ๊ธฐ๊ฐ„
๊ธฐ๊ด€ ์ˆ˜
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
2025Q4
34
465.80K
9.90%
--
2025Q3
47
465.80K
18.84%
-72.37K
2025Q2
50
538.17K
21.64%
+180.74K
2025Q1
80
357.43K
67.10%
-16.79M
2024Q4
85
305.49K
75.32%
+42.45K
2024Q3
88
263.04K
299.72%
-979.92K
2024Q2
90
1.24M
285.03%
-389.76K
2024Q1
94
1.63M
272.11%
-20.00M
2023Q4
94
1.73M
289.40%
-2.99M
2023Q3
93
4.71M
469.75%
-226.48K
๋” ๋ณด๊ธฐ

์ฃผ์ฃผ ํ™œ๋™

๎™Œ
์ด๋ฆ„
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
Chg %
๋‚ ์งœ
Wu (Haimei)
18.30M
68.9%
+18.30M
--
May 13, 2025
ExcelFin SPAC LLC
4.77M
17.98%
-976.59K
-16.98%
May 13, 2025
Grand Fortune Capital (H.K.) Co, Ltd.
2.46M
9.28%
+2.46M
--
May 13, 2025
Periscope Capital
125.00K
0.47%
--
--
Sep 30, 2025
Highbridge Capital Management, LLC
125.00K
0.47%
--
--
Sep 30, 2025
Citadel Advisors LLC
46.53K
0.18%
+46.53K
--
Sep 30, 2025
UBS Financial Services, Inc.
65.82K
0.25%
-25.63K
-28.03%
Sep 30, 2025
Geode Capital Management, L.L.C.
25.44K
0.1%
--
--
Sep 30, 2025
๋” ๋ณด๊ธฐ

๊ด€๋ จ ETF

๎™Œ
์ด๋ฆ„
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ

์ฃผ์‹ ๋ฐฐ๋‹น๊ธˆ

๎™Œ
์ง€๋‚œ 5๋…„ ๋™์•ˆ ์ด 0.00 USD์˜ ๋ฐฐ๋‹น๊ธˆ์ด ๋ถ„๋ฐฐ๋˜์—ˆ์Šต๋‹ˆ๋‹ค.
๋‚ ์งœ
๋ฐฐ๋‹น๊ธˆ
๊ธฐ์ค€์ผ
์ง€๊ธ‰์ผ
๋ฐฐ๋‹น๋ฝ์ผ
๋ฐ์ดํ„ฐ ์—†์Œ

์ฃผ์‹ ๋ถ„ํ• 

๎™Œ
๋‚ ์งœ
๋ฐฐ๋‹น๋ฝ์ผ
์œ ํ˜•
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ
๋‚ ์งœ
๋ฐฐ๋‹น๋ฝ์ผ
์œ ํ˜•
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ
KeyAI
๎™